These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss. Lee K; Yong D; Choi YS; Yum JH; Kim JM; Woodford N; Livermore DM; Chong Y Int J Antimicrob Agents; 2007 Feb; 29(2):201-6. PubMed ID: 17204406 [TBL] [Abstract][Full Text] [Related]
6. First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital. Kassis-Chikhani N; Decré D; Gautier V; Burghoffer B; Saliba F; Mathieu D; Samuel D; Castaing D; Petit JC; Dussaix E; Arlet G J Antimicrob Chemother; 2006 Jan; 57(1):142-5. PubMed ID: 16284103 [TBL] [Abstract][Full Text] [Related]
7. Spread of plasmids containing the bla(VIM-1) and bla(CTX-M) genes and the qnr determinant in Enterobacter cloacae, Klebsiella pneumoniae and Klebsiella oxytoca isolates. Miró E; Segura C; Navarro F; Sorlí L; Coll P; Horcajada JP; Alvarez-Lerma F; Salvadó M J Antimicrob Chemother; 2010 Apr; 65(4):661-5. PubMed ID: 20089541 [TBL] [Abstract][Full Text] [Related]
8. Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil. Peirano G; Seki LM; Val Passos VL; Pinto MC; Guerra LR; Asensi MD J Antimicrob Chemother; 2009 Feb; 63(2):265-8. PubMed ID: 19028717 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates. Kim SY; Park YJ; Yu JK; Kim HS; Park YS; Yoon JB; Yoo JY; Lee K Diagn Microbiol Infect Dis; 2007 Jan; 57(1):85-91. PubMed ID: 16854555 [TBL] [Abstract][Full Text] [Related]
10. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases. Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696 [TBL] [Abstract][Full Text] [Related]
11. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals. Ensor VM; Shahid M; Evans JT; Hawkey PM J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956 [TBL] [Abstract][Full Text] [Related]
12. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases. Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087 [TBL] [Abstract][Full Text] [Related]
13. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD. Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142 [TBL] [Abstract][Full Text] [Related]
14. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria). Messai Y; Iabadene H; Benhassine T; Alouache S; Tazir M; Gautier V; Arlet G; Bakour R Pathol Biol (Paris); 2008 Jul; 56(5):319-25. PubMed ID: 18585867 [TBL] [Abstract][Full Text] [Related]
15. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. Carvalhaes CG; Picão RC; Nicoletti AG; Xavier DE; Gales AC J Antimicrob Chemother; 2010 Feb; 65(2):249-51. PubMed ID: 19996141 [TBL] [Abstract][Full Text] [Related]
16. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden. Samuelsen Ø; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG J Antimicrob Chemother; 2009 Apr; 63(4):654-8. PubMed ID: 19218573 [TBL] [Abstract][Full Text] [Related]
17. Imipenem resistance in Klebsiella pneumoniae is associated to the combination of plasmid-mediated CMY-4 AmpC β-lactamase and loss of an outer membrane protein. Dahmen S; Mansour W; Charfi K; Boujaafar N; Arlet G; Bouallègue O Microb Drug Resist; 2012 Oct; 18(5):479-83. PubMed ID: 22690752 [TBL] [Abstract][Full Text] [Related]
18. Detection of the new metallo-beta-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in Klebsiella pneumoniae. Pournaras S; Poulou A; Voulgari E; Vrioni G; Kristo I; Tsakris A J Antimicrob Chemother; 2010 Aug; 65(8):1604-7. PubMed ID: 20522444 [TBL] [Abstract][Full Text] [Related]
19. [Identification and expression of blaCTX-M-14 and blaCTX-M-24]. Xiong ZZ; Zhu DM; Wang F; Zhang YY Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1454-9. PubMed ID: 15500745 [TBL] [Abstract][Full Text] [Related]
20. Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain. Curiao T; Morosini MI; Ruiz-Garbajosa P; Robustillo A; Baquero F; Coque TM; Cantón R J Antimicrob Chemother; 2010 Aug; 65(8):1608-14. PubMed ID: 20513703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]